BrainStorm Strengthens Executive Team with Key Appointments in R&D and Legal
/PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, announced two...
Source: prnewswire.com